Home›Stock Screener›Wanbury

Wanbury Share Price Today | Stock Price & Wanbury Share Screener

WANBURY Pharmaceuticals & Biotechnology
Live Share Price NSE
₹181.66
▲ 7.28 (4.17%)
2026-11-19 00:00:00
Live Share Price BSE
₹182.55
▲ 8.55 (4.91%)
2026-11-19 00:00:00

As of November 19, 2026, the live Wanbury share price (NSE: WANBURY) is ₹181.66 on NSE and ₹182.55 on BSE, up 4.17% from the previous close, with shares trading between ₹170.25 and ₹183.00 in today's trading session, and a 52-week range of ₹163.34–₹344.75. Track Wanbury marketcap in USD to gauge the company's total market size. Use the Wanbury stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Wanbury opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹183 and net income of ₹9, with EBITDA of ₹23, an operating margin of 12.0% and a profit margin of 4.9%.

Wanbury Market Cap ₹676.47 Cr.
WANBURY P/E Ratio (TTM) 13.30
Wanbury P/B Ratio 4.38
EPS (TTM) ₹9.32
Dividend Yield -
Debt to Equity 3.38
WANBURY 52 Week High ₹344.75
Wanbury 52 Week Low ₹163.34
Operating Margin 12.00%
Profit Margin 4.92%
WANBURY Revenue (TTM) ₹183.00
EBITDA ₹23.00
Net Income ₹9.00
Total Assets ₹414.00
Total Equity ₹59.00

Wanbury Share Price Chart

Track the current stock price of Wanbury with an interactive chart. Analyse WANBURY share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Wanbury stock quote in one place.

The quote of ₹181.66 sits between the 52-week low of ₹163.34 and the 52-week high of ₹344.75, and the latest session moved 4.17% from the previous close.

Wanbury Company Profile - Fundamental Screener

Screen Wanbury company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for WANBURY shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals & Biotechnology industry, and it trades under ISIN INE107F01022.

Company Details

Classification

Sector Healthcare
Industry Pharmaceuticals & Biotechnology
Sub-Sector Pharmaceuticals & Biotechnology
Segment E

Identifiers and Leadership

ISIN INE107F01022

Wanbury Balance Sheet Screener

Screen WANBURY balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2025, total assets were ₹414, up from ₹344 in 2024.

Latest statistics put total assets at ₹414 and shareholder funds at ₹59, with a leverage ratio of 3.38.

Item 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016

Assets

Total Assets 414 344 304 353 289 279 286 273 412 388
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 201 167 167 167 167 164 172 178 186 180

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 180 101 16 16 90 111 134 109 163 251
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 59 28 -33 -23 -156 -144 -209 -185 -153 -162
Share Capital 33 33 33 33 25 25 24 24 23 20
Reserves & Surplus 21 -11 -66 -56 -181 -168 -233 -208 -177 -221

Wanbury Income Statement Screener - Profit & Revenue Analysis

Screen Wanbury income statement and profit fundamentals. Analyze WANBURY quarterly results. Wanbury reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Sept, revenue was ₹183 and net profit was ₹9, equal to earnings per unit of ₹2.44, at an operating margin of 12%.

In that period expenses were ₹160, interest cost ₹6 and tax ₹4. The next period listed, 2026-Jun, shows revenue of ₹166 and net profit of ₹3.

Item 2026-Sept 2026-Jun 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept 2022-Jun

Revenue and Expenses

Revenue 183 166 164 174 134 163 132 166 146 145 147 131 126 125 119
Expenses 160 149 139 142 120 141 120 121 124 127 133 119 119 118 120

Operating Costs and Margins

EBITDA 23 17 25 32 15 22 12 45 22 18 14 12 7 6 -1
Operating Profit % 12.00% 10.00% 15.00% 17.00% 10.00% 12.00% 8.00% 13.00% 15.00% 12.00% 9.00% 10.00% 5.00% 5.00% -3.00%
Depreciation 4 4 4 3 3 3 3 3 3 3 3 3 3 3 3
Interest 6 8 8 9 10 10 8 8 8 8 6 8 7 4 3

Profit and Earnings

Profit Before Tax 12 5 14 19 1 8 1 34 10 7 5 1 -3 -1 -7
Tax 4 1 0 -1 0 0 0 0 0 0 0 0 0 0 0
Net Profit 9 3 14 20 1 8 1 34 10 7 5 1 -3 -1 -7
EPS 2.44 0.93 4.12 6.18 0.38 2.44 0.32 10.28 3.14 2.25 1.43 0.31 -1.00 -0.27 -2.22

Wanbury Cash Flow Screener - Liquidity Fundamentals

Screen WANBURY cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2025-March, operating activities generated ₹26, and net cash flow was an inflow of ₹1.

Over the same period, investing activities used ₹51 and financing activities provided ₹26.

Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March

Cash from Operations and Investing

Operating Activities 26 4 20 41 17 44 30 33 43 43
Investing Activities -51 -17 -9 1 8 64 -3 -1 -13 -20

Financing and Net Cash

Financing Activities 26 15 -32 -29 -17 -108 -27 -33 -27 -28
Net Cash Flow 1 2 -21 13 7 0 0 -2 3 -5

Wanbury Shareholding Pattern Screener

See Wanbury shareholding pattern with promoter, FII, and DII holdings. Check Wanbury promoter holding and ownership changes for WANBURY on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 43.02%, foreign institutions 0.59%, domestic institutions 0.00% and the public 42.17%, spread across 16,732 shareholders.

The shareholder count was 16,732 in 2026-Mar, compared with 17,174 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 43.02% 43.02% 42.98% 39.76% 39.63% 43.09% 43.07% 39.79%

Institutional Investors

FII Holding 0.59% 0.89% 0.71% 1.55% 1.59% 0.82% 0.72% 0.18%
DII Holding 0.00% 0.06% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 42.17% 41.91% 42.00% 41.78% 42.06% 41.19% 41.28% 41.81%
Other Holding 14.23% 14.12% 14.28% 16.90% 16.71% 14.89% 14.92% 18.22%
Shareholder Count 16,732 17,174 20,432 17,889 17,894 17,717 17,261 13,087

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Wanbury. Wanbury dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Wanbury.

Wanbury Stock Index Membership - Nifty & Sensex

See which indices include Wanbury stock. Check WANBURY index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Wanbury is not part of any tracked indices.
Only major market indices are tracked in our system.

Wanbury Market Events Screener - Corporate Actions

Get Wanbury corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Wanbury stock events that may affect WANBURY share price, along with derivatives, futures and options activity and sector gainers.

15 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 4, 2026, with a record date of November 4, 2026.

It is followed by Annual General Meeting dated September 24, 2026 and Quarterly Result Announcement dated August 11, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-04 2026-11-04 Quarterly Result Announcement NA 9.45%
2026-09-24 2026-09-24 Annual General Meeting NA -9.41%
2026-08-11 2026-08-11 Quarterly Result Announcement NA -16.19%
2026-05-29 2026-05-29 Quarterly Result Announcement NA 18.63%
2026-02-05 2026-02-05 Quarterly Result Announcement NA 58.44%
2026-01-05 2026-01-05 Extraordinary General Meeting NA 1.20%
2025-11-13 2025-11-13 Quarterly Result Announcement NA -8.84%
2025-09-18 2025-09-18 Annual General Meeting NA -12.35%
2025-08-04 2025-08-04 Quarterly Result Announcement NA 9.64%
2025-05-15 2025-05-15 Quarterly Result Announcement NA 11.57%
2025-02-20 2025-02-20 Extraordinary General Meeting NA -25.55%
2025-02-12 2025-02-12 Quarterly Result Announcement NA -11.84%
2024-11-13 2024-11-13 Quarterly Result Announcement NA 10.56%
2024-09-27 2024-09-27 Annual General Meeting NA 15.79%
2023-09-27 2023-09-27 Annual General Meeting NA 27.65%

Wanbury Competitors Screener - Peer Stocks Comparison

Screen WANBURY competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Sun Pharmaceutical 451,075 41.20 61,674 12.69% 11,565 63.60
Divis Laboratories 303,749 90.40 11,067 13.95% 2,568 78.53
Torrent Pharmaceuticals 177,632 85.50 13,886 20.34% 2,138 47.27
Laurus Labs 130,972 97.10 6,868 22.01% 890 69.60
Zydus Life Science 118,693 28.00 27,658 17.64% 5,026 52.34
Dr Reddys Laboratories 115,186 42.00 35,059 3.90% 4,158 70.24
Cipla 112,438 39.90 29,045 2.24% 3,870 54.92
Mankind Pharma 109,044 48.10 14,636 14.85% 1,938 65.43
Aurobindo Pharma 104,903 26.00 34,145 5.56% 3,503 66.06
Lupin 90,557 17.60 29,039 26.75% 5,356 44.92

Wanbury Company Announcements - News & Reports Screener

Screen WANBURY latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 18, 2026.

The next most recent announcements are dated November 12, 2026 and November 4, 2026.

Date Update Actions
2026-11-18 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-12 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-11-04 Financial Results As On 30Th September 2026 -
2026-11-04 Board Meeting Outcome for Outcome Of The Board Meeting Held On November 04 2026 -
2026-10-30 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-28 Board Meeting Intimation for Wanbury Limited Is Scheduled To Be Held On Wednesday November 04 2026 Inter-Alia To Consider And Approve The Un-Audited Financial Results (Standalone & Consolidated) For The Second Quarter And Half Year Ended September 30 2026 -
2026-10-19 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-16 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-12 Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised) -
2026-10-12 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-10-09 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-08 Announcement under Regulation 30 (LODR)-Press Release / Media Release -
2026-09-29 Closure of Trading Window -
2026-09-25 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-24 Announcement under Regulation 30 (LODR)-Change in Management -
2026-09-24 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-02 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-31 Notice Of Book Closure For The Purpose Of 38Th Annual General Meeting (AGM). -
2026-08-31 Reg. 34 (1) Annual Report. -
2026-08-31 Annual Report 2025-26 And Notice Of The 38Th Annual General Meeting Of Wanbury Limited. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹181.66, within a 52-week range of ₹163.34 to ₹344.75. The P/E ratio is 13.30 and the P/B ratio is 4.38, with earnings per unit of ₹9.32. Market capitalisation stands at ₹676.47 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals & Biotechnology industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on November 21, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.